Riskpilot← Back to searchSign inGet full accessDR. KARI AS
ASActiveOrg 916685831Utkikken 7, 4843 ArendalAllmenn legetjeneste · NACE 86211Est. 20160 employees
Revenue 2023
NOK 316K
-29% vs 2022
EBITDA margin
50.9%
-45% vs 2022
Equity ratio
61.5%
Financial strength
Net profit 2023
NOK 125K
-45% vs 2022
| Revenue | NOK 316K | -29% |
| EBITDA | NOK 160K | -45% |
| Net profit | NOK 125K | -45% |
| Total assets | NOK 252K | -43% |
| Equity | NOK 155K | +416% |
| Employees | 0 | — |
Legal name
DR. KARI AS
Org number
916685831
Legal form
Aksjeselskap
NACE code
86211 · Allmenn legetjeneste
Founded
4. februar 2016
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Legevirksomhet med behandling der det brukes samtale, kognitive terapi og hypnoterapi (bruk av klinisk hypnose) og kursvirksomhet. Samt annet som står i forbindelse med dette, herunder deltakelse i andre selskap.
Address
Utkikken 7, 4843 Arendal
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 1 085 | 553 | 248 | 445 | 316 |
| Staff expenses | −329 | −218 | −3 | −7 | −4 |
| EBITDA | 272 | 26 | 80 | 293 | 160 |
| Depreciation & amort. | −59 | −3 | −0 | −0 | −0 |
| EBIT | 213 | 23 | 80 | 293 | 160 |
| Net financials | 1 | 0 | 0 | 0 | 0 |
| Profit before tax | 214 | 24 | 80 | 293 | 161 |
| Tax | 48 | 6 | 19 | 65 | 35 |
| Net profit | 166 | 18 | 61 | 228 | 125 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 1 579 | 503 | 274 | 440 | 252 |
| Equity | 678 | 45 | 107 | 30 | 155 |
| Long-term debt | 131 | 91 | 73 | 58 | 46 |
| Short-term debt | 770 | 367 | 95 | 352 | 51 |
| Total debt | 901 | 458 | 167 | 410 | 97 |
EBITDA margin
50.9%
This company
15.8%
Market median
+222% vs market
20192023
Equity ratio
61.5%
This company
38.2%
Market median
+61% vs market
20192023
Return on equity
80.6%
This company
18.4%
Market median
+338% vs market
20192023
Net profit margin
39.7%
This company
8.1%
Market median
+390% vs market
20192023
Asset turnover
1.25×
This company
1.12×
Market median
+12% vs market
20192023
Debt / equity
0.63×
This company
0.62×
Market median
+2% vs market
20192023
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
KH Chief Executive Officer | Chief Executive Officer | 2016 |
OK Deputy Member | Deputy Member | 2016 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DR. KARI AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kari Hilde Juvkam | Chief Executive Officer | 0 companies |
| Olav Knudsen-Baas | Deputy Member | 0 companies |